Latest Articles

Publication Date
Acrivon Therapeutics Spotlights ACR368 Endometrial Cancer Data, Adds Serous Arm 3 and FDA Phase 3 Plan - Defense World

Acrivon Therapeutics Spotlights ACR368 Endometrial Cancer Data, Adds Serous Arm 3 and FDA Phase 3 Plan Defense World

Published: Jan. 10, 2026, 6:12 a.m.
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 - Sahm

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 …

Published: Jan. 9, 2026, 6:18 a.m.
Acrivon Stock Sinks 29% Despite Positive Phase 2b Endometrial Cancer Data - Nasdaq

Acrivon Stock Sinks 29% Despite Positive Phase 2b Endometrial Cancer Data Nasdaq

Published: Jan. 8, 2026, 7:14 p.m.
Flu: Cases in Northern Ireland fall after December surge - BBC

Flu: Cases in Northern Ireland fall after December surge BBC

Published: Jan. 8, 2026, 4:36 p.m.
Dr. Jessica Ritch Opens EnRitched Gynecology, a New Membership-Based Women’s Health Practice - Rutland Herald

Dr. Jessica Ritch Opens EnRitched Gynecology, a New Membership-Based Women’s Health Practice Rutland Herald

Published: Jan. 8, 2026, 4:15 p.m.
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 - The Manila Times

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 …

Published: Jan. 8, 2026, 12:53 p.m.
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b - GlobeNewswire

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b GlobeNewswire

Published: Jan. 8, 2026, 12:30 p.m.
Small-Cap Acrivon Showcases Tumor Reduction and Clinical Advancement in Major Trials, Shares Decline - Bitget

Small-Cap Acrivon Showcases Tumor Reduction and Clinical Advancement in Major Trials, Shares Decline Bitget

Published: Jan. 8, 2026, 3:12 a.m.
Does menopause increase endometrial cancer risk? | Tap to know more | Inshorts - Inshorts

Does menopause increase endometrial cancer risk? | Tap to know more | Inshorts Inshorts

Published: Jan. 4, 2026, 7:43 a.m.
Aspira Women’s Health showcases AI ovarian diagnostics platform - MSN

Aspira Women’s Health showcases AI ovarian diagnostics platform MSN

Published: Jan. 1, 2026, 9:51 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!